ERS/ATS joint webinar: Rehabilitation after COVID 19 disease

T. Troosters (Leuven, Belgium), A. Holland (Fitzroy North, Australia), M. A Spruit (Maastricht, Netherland), S. Singh (Leicester, United kingdom), L. Nici (Providence, USA), W. Janssens (Leuven, Belgium), M. Vittacca (Gussago, Italy), J. Raskin (New York, USA), S. Belli (Somma Lombardo, Italy), D. Janssen (Horn, Netherlands)

Source: ERS webinar 2020: ERS/ATS joint webinar: Rehabilitation after COVID 19 disease
Number: 0
Disease area: Respiratory infections

WebcastSlide presentation

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Troosters (Leuven, Belgium), A. Holland (Fitzroy North, Australia), M. A Spruit (Maastricht, Netherland), S. Singh (Leicester, United kingdom), L. Nici (Providence, USA), W. Janssens (Leuven, Belgium), M. Vittacca (Gussago, Italy), J. Raskin (New York, USA), S. Belli (Somma Lombardo, Italy), D. Janssen (Horn, Netherlands). ERS/ATS joint webinar: Rehabilitation after COVID 19 disease. ERS webinar 2020: ERS/ATS joint webinar: Rehabilitation after COVID 19 disease

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Assessment
Source: ERS webinar 2020: ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Assessment
Year: 2020

ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Programme
Source: ERS webinar 2020: ERS/ATS joint webinar on rehabilitation after COVID 19 disease: Q&A on Programme
Year: 2020

Diagnosis and treatment of COVID-19
Source: Webinar 2020: Diagnosis and treatment of COVID-19
Year: 2020

SARS-CoV-2 (COVID-19): Research response
Source: Webinar 2020: SARS-CoV-2 (COVID-19): research response
Year: 2020

COVID-19: Q and A
Source: ERS Webinar 2020: COVID-19: Q and A
Year: 2020

Perspectives of the management of COVID-19 infection in China
Source: Webinar 2020: Perspectives of the management of COVID-19 infection in China
Year: 2020

Coronavirus disease: outbreak in China and globally
Source: Webinar 2020
Year: 2020

Update on respiratory virus research and clinical care including influenza outbreak 2017-18, SARS, MERS and other respiratory pathogens
Source: International Congress 2018 – PG3 How to plan for and manage a respiratory epidemic/pandemic
Year: 2018


Health Policy of COVID-19 management
Source: ERS Webinar 2020: Health Policy of COVID-19 management
Year: 2020

Interview on Coronavirus COVID-19 management experience in China
Source: Webinar 2020: Interview on Coronavirus COVID-19 management experience in China
Year: 2020

Human metapneumovirus and community-acquired pneumonia: a pediatric survey
Source: Annual Congress 2005 - New insights in respiratory infections in children
Year: 2005


The comaprison of clinical characteristics and courses of pediatric patients hospitalized with pandemic influenza A (H1N1) and seasonal influenza in Korea from 2009-2011
Source: International Congress 2014 – Prevention, diagnosis and consequences of respiratory infections in children
Year: 2014


Rapid spread of the novel respiratory syncytial virus A ON1 genotype, during the epidemic seasons 2011-2013
Source: International Congress 2014 – Virus-triggered lower respiratory disease in children
Year: 2014


RSV and human metapneumovirus – major pathogens of childhood – also adults and the elderly?
Source: Annual Congress 2005 - Major viral threats to the lung
Year: 2005

Epidemic and pandemic viral infections: impact on tuberculosis and the lung
Source: Eur Respir J, 56 (4) 2001727; 10.1183/13993003.01727-2020
Year: 2020



Clinical features of influenza virus infection of 2013/2014 season
Source: International Congress 2015 – Viral infections: basic research and clinical perspective
Year: 2015


Respiratory syncytial virus infection in childcare and hospitalized children with different respiratory disease severity
Source: Annual Congress 2006 - Virus-induced respiratory tract infection
Year: 2006


A nosocomial outbreak of influenza during a period without influenza epidemic activity
Source: Eur Respir J 2003; 21: 303-307
Year: 2003



Can procalcitonin (PCT) be an indicator of viral severe community-acquired pneumonia (CAP) based on epidemics of influenza H1N1 in season 2015-2016?
Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab
Year: 2016


Influenza type A outbreak associated with myositis
Source: Annual Congress 2005 - Host-pathogen interaction in respiratory virus infections
Year: 2005